Pharmaceuticals News and Research

RSS

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced US$16.7 million to support development of new compounds for fighting malaria and tuberculosis, a leishmaniasis vaccine and drug, and a treatment for a long-ignored flesh-eating infection.

31 Oct 2017

Deep-learning technology reveals anti-aging plant extracts

Life Extension, in collaboration with Insilico Medicine, have employed artificial intelligence to develop a novel dietary supplement of plant extracts that can activate the body's own anti-aging path ways.

31 Oct 2017

UTHealth professor receives $2.6 million NIH award for brain research

The National Institutes of Health has presented its Maximizing Investigators' Research Award to Vasanthi Jayaraman, Ph.D., a professor of biochemistry and molecular biology with McGovern Medical School at The University of Texas Health Science Center at Houston. It is a $2.6 million, five-year award.

30 Oct 2017

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Less than half of patients received their insurer's approval for prescriptions of PCSK9 inhibitors, according to new research in the American Heart Association's journal Circulation.

30 Oct 2017

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya (fingolimod) vs. interferon beta-1a, in children and adolescents (ages 10 to 17) with multiple sclerosis (MS).

30 Oct 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Novel consortium aims to create new paradigm of cancer drug discovery

Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.

27 Oct 2017

Pharmacist identifies protein linked to tumor growth in gallbladder cancer

Patients with gallbladder cancer often show few or no symptoms for long periods of time. As a result, the tumors are only detected at a late stage of the disease when treatment is often no longer possible.

25 Oct 2017

The painful side of positive health care marketing

Lori Wallace sits on a couch with her 11-year-old son and his new pet snake. It burrows under his armpit, as if afraid. Wallace is sure it’s not.

25 Oct 2017

Researchers mine blood-based epigenetic data to gain insights into autism biology

Using data from blood and brain tissue, a team led by researchers at Johns Hopkins Bloomberg School of Public Health found that they could gain insights into mechanisms that might help explain autism by analyzing the interplay between genes and chemical tags that control whether genes are used to make a protein, called epigenetic marks.

25 Oct 2017

Antidepressant use in children, adolescents linked to increased risk of type 2 diabetes

A team of researchers from the University of Maryland School of Pharmacy and the University of Maryland School of Medicine found that current (prolonged) use of serotonin reuptake inhibitors – a major class of antidepressant medications – in children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes when compared to youths who formerly used (but eventually discontinued) those medications.

24 Oct 2017

Brazilian scientists examine how benzopyrene can cause cancer

Benzo[a]pyrene is a potent carcinogen and mutagen present in cigarette smoke, automotive exhaust, burnt wood fumes, barbecued and smoked meat etc.

23 Oct 2017

Research could pave way to cure for type 2 diabetes

In healthy people, exosomes - tiny structures secreted by cells to allow intercellular communication - prevent clumping of the protein that leads to type 2 diabetes.

23 Oct 2017

Blood levels of thyroid hormone may help identify individuals at risk for irregular heartbeat

Individuals with higher levels of thyroid hormone (free thyroxine, FT4) circulating in the blood were more likely than individuals with lower levels to develop irregular heartbeat, or atrial fibrillation, even when the levels were within normal range, according to new research in the American Heart Association's journal Circulation.

23 Oct 2017

African Americans have shorter lifespan because of heart disease and stroke

The average lifespan of African Americans is significantly shorter than white Americans, mostly because of heart disease and stroke, which contributed to more than two million years of life lost among African Americans between 1999 and 2010, according to a new scientific statement published in the American Heart Association's journal Circulation.

23 Oct 2017

RAND researchers estimate health care savings over next decade from biosimilars

Introducing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut health care spending in the United States by $54 billion over the next decade, according to new analysis from the RAND Corporation.

23 Oct 2017

Pharmaceuticals News and Research

GHIT Fund announces US$16.7 million to support development of new drugs, vaccines and diagnostics

Deep-learning technology reveals anti-aging plant extracts

UTHealth professor receives $2.6 million NIH award for brain research

Study: Less than half of patients receive insurer's approval for prescription of cholesterol drugs

Novartis PARADIGMS study shows safety and efficacy of new treatment in pediatric MS patients

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Novel consortium aims to create new paradigm of cancer drug discovery

Pharmacist identifies protein linked to tumor growth in gallbladder cancer

The painful side of positive health care marketing

Researchers mine blood-based epigenetic data to gain insights into autism biology

Antidepressant use in children, adolescents linked to increased risk of type 2 diabetes

Brazilian scientists examine how benzopyrene can cause cancer

Research could pave way to cure for type 2 diabetes

Blood levels of thyroid hormone may help identify individuals at risk for irregular heartbeat

African Americans have shorter lifespan because of heart disease and stroke

RAND researchers estimate health care savings over next decade from biosimilars

Osteocytes play crucial role as major source of RANKL during orthodontic tooth movement

UC San Diego researchers develop 3D visualization tool for mapping omics data onto organs

New vaccine for pneumonia holds promise to save thousands of lives

New procedure expands options open for carrying out tests on human brain cells

Industry Focus - Biopharma eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring